Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio

The liquid biopsy market is poised to grow by USD 4.02 billion during 2020-2024, progressing at a CAGR of almost 38% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201023005398/en/

Technavio has announced its latest market research report titled Global Liquid Biopsy Market 2020-2024 (Graphic: Business Wire)

Technavio has announced its latest market research report titled Global Liquid Biopsy Market 2020-2024 (Graphic: Business Wire)

The report on the liquid biopsy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing funding for liquid biopsy.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis

The liquid biopsy market analysis includes the technology segment and geographic landscapes. This study identifies the growing focus on personalized medicine for cancer care as one of the prime reasons driving the liquid biopsy market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The Liquid Biopsy Market covers the following areas:

Liquid Biopsy Market Sizing

Liquid Biopsy Market Forecast

Liquid Biopsy Market Analysis

Companies Mentioned

  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • LungLife AI Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • SAGA Diagnostics AB

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Technology

  • Market segments
  • Comparison by Technology
  • CTC and ctDNA - Market size and forecast 2019-2024
  • Exosome and RNA - Market size and forecast 2019-2024
  • Market opportunity by Technology

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • LungLife AI Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • SAGA Diagnostics AB

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts:

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.